Keytruda (pembrolizumab) - Merck (MSD)
VTP-600 - Vaccitech
https://oncologypro.esmo.org/meeting-resources/esmo-congress/a-phase-i-iia-trial-of-chadox1-and-mva-vaccines-against-mage-a3-and-ny-eso-1
 
F. Blackhall1; L. Moliner1; A. Samson2; K. Franks3; I. Karydis4; D. Joseph-Pietras5; O. Frank5; H. Lavender5; M. Jannoo6; M. Marshall7; P. Motteram7; B.J. van den Eynde8; C. Leung9; A. Hill10; M.R. Middleton11; N.A. Coupe11; N. Steele12; J. Spicer13; P.H. Shaw14; S.N. Symeonides15
 
Jul 27, 2023
 
Next